Long pages

Showing below up to 50 results in range #101 to #150.

101. (hist) Experiential learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in India [1,317 bytes]
102. (hist) MR Imaging Features of Nipah Encephalitis [1,317 bytes]
103. (hist) The Ecology of Nipah Virus in Bangladesh: A Nexus of Land-Use Change and Opportunistic Feeding Behavior in Bats [1,310 bytes]
104. (hist) Infectious disease and economics: The case for considering multi-sectoral impacts [1,308 bytes]
105. (hist) Molecular Pathogenesis of Nipah Virus [1,303 bytes]
106. (hist) Experimental Infection of Syrian Hamsters With Aerosolized Nipah Virus [1,301 bytes]
107. (hist) Impact of Plantation Induced Forest Degradation on the Outbreak of Emerging Infectious Diseases—Wayanad District, Kerala, India [1,299 bytes]
108. (hist) Piloting the promotion of bamboo skirt barriers to prevent Nipah virus transmission through date palm sap in Bangladesh [1,298 bytes]
109. (hist) Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis [1,293 bytes]
110. (hist) Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature [1,290 bytes]
111. (hist) Nipah Virus Transmission from Bats to Humans Associated with Drinking Traditional Liquor Made from Date Palm Sap, Bangladesh, 2011–2014 [1,287 bytes]
112. (hist) Nipah virus: a re-emerging public health concern [1,282 bytes]
113. (hist) Ribavirin Therapy for Nipah Virus Infection [1,279 bytes]
114. (hist) Nipah Virus-associated Encephalitis Outbreak, Siliguri, India [1,269 bytes]
115. (hist) Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018 [1,267 bytes]
116. (hist) Functional and antigenic landscape of the Nipah virus receptor-binding protein [1,264 bytes]
117. (hist) Assessing the feasibility of Nipah vaccine effliciency trials based on previous outbreaks in Bangladesh [1,264 bytes]
118. (hist) Projecting vaccine demand and impact for emerging zoonotic pathogens [1,262 bytes]
119. (hist) Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents [1,260 bytes]
120. (hist) Trends in Bacterial Pathogens of Bats: Global Distribution and Knowledge Gaps [1,252 bytes]
121. (hist) Full genome sequence of Nipah virus from an outbreak in India [1,242 bytes]
122. (hist) Transmission of Nipah Virus — 14 Years of Investigations in Bangladesh [1,241 bytes]
123. (hist) Outbreak prone communicable diseases of public health importance in the northern districts of West Bengal – Current status & the way forward [1,240 bytes]
124. (hist) Science. 2022 March 25; 375(6587): 1373–1378. [1,238 bytes]
125. (hist) Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters [1,234 bytes]
126. (hist) Bats and viruses: a death-defying friendship [1,232 bytes]
127. (hist) Metagenomic Snapshots of Viral Components in Guinean Bats [1,230 bytes]
128. (hist) Clinical Medicine 2022 Vol 22, No 4: 348–52 - Review of Nipah virus encephalitis [1,230 bytes]
129. (hist) A Comparative Analysis of Statistical Methods to Estimate the Reproduction Number in Emerging Epidemics, With Implications for the Current Coronavirus Disease 2019 (COVID-19) Pandemic [1,230 bytes]
130. (hist) Nipah Virus: An Overview of the Current Status of Diagnostics and Their Role in Preparedness in Endemic Countries [1,226 bytes]
131. (hist) Host–Pathogen Interactions Influencing Zoonotic Spillover Potential and Transmission in Humans [1,218 bytes]
132. (hist) Controlling Nipah virus encephalitis in Bangladesh: Policy options [1,218 bytes]
133. (hist) Nipah amidst Covid-19 Pandemic – another Re-Emerging Infectious Disease of Pandemic Potential – a Narrative Review [1,217 bytes]
134. (hist) Beyond the Headlines: Why Henipaviruses Warrant Our Attention [1,212 bytes]
135. (hist) Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials [1,211 bytes]
136. (hist) A review of the nipah virus [1,211 bytes]
137. (hist) Aerosol exposure to intermediate size Nipah virus particles induces neurological disease in African green monkeys [1,207 bytes]
138. (hist) Pathogenicity and virulence of henipaviruses [1,207 bytes]
139. (hist) Discovery of a Novel Parahenipavirus, Parahenipavirus GH, in Shrews in South Korea, 2022 [1,206 bytes]
140. (hist) Super-spreaders of novel coronaviruses that cause SARS, MERS and COVID-19: a systematic review [1,203 bytes]
141. (hist) Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease [1,202 bytes]
142. (hist) Navigating Nipah virus: Insights, challenges, and recommendations [1,199 bytes]
143. (hist) Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics [1,198 bytes]
144. (hist) Nipah virus: pathogenesis, genome, diagnosis, and treatment [1,197 bytes]
145. (hist) Recurrent Nipah outbreaks in Kerala: implications for health policy and preparedness [1,195 bytes]
146. (hist) Hendra and Nipah viruses: different and dangerous [1,195 bytes]
147. (hist) Exact calculation of end-of-outbreak probabilities using contact tracing data [1,191 bytes]
148. (hist) Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report [1,189 bytes]
149. (hist) An Immunoinformatic-Based In Silico Identification on the Creation of a Multiepitope-Based Vaccination Against the Nipah Virus [1,188 bytes]
150. (hist) Letter to editor: Serosurvey for Nipah virus in bat population of southern part of India [1,186 bytes]